Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
Simone Claudiani,
Jane F. Apperley,
Afzal Khan,
Jamshid Khorashad,
Dragana Milojkovic
Affiliations
Simone Claudiani
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London;Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK
Jane F. Apperley
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London;Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK
Afzal Khan
Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK
Jamshid Khorashad
Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK
Dragana Milojkovic
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London